Definitive Healthcare Corp. (DH)

Definitive Healthcare screens as a deep-value, cash-generative SaaS at a distressed market price (EV/Sales ~0.27; free-cash-flow yield ~42%), backed by meaningful liquidity (~$171M cash vs ~$152M debt per the latest 10-Q). The counterweight is fundamentals that are still deteriorating on the income statement—revenue is down year over year and GAAP profitability remains very weak due to large impairment charges—plus a Nasdaq minimum bid-price compliance issue. Overall this is more of a high-uncertainty turnaround/watchlist than a clean, low-risk fundamental story.

Bearish-tilted setup: the actionable catalyst set is entirely adverse — a S&P Global BMI index deletion (technical, announced, 2026-09-21) that landed alongside a BofA downgrade on competitive pressures and analyst target cuts, plus an unresolved Nasdaq continued-listing deficiency with the stock still below $1. Sentiment delta is flat-to-negative (baseline ≈ +0.01 → scoring ≈ −0.01, sole on-topic scored item −0.3) with retail indeterminate; moderate red-flag cap applied (deteriorating sentiment, no offsetting bullish catalyst).

DH at $0.93 is a sub-$1 healthcare-data name still inside a primary downtrend: price sits ~28% below the SMA200 (1.29) with the SMA50 (0.80) below the SMA200, and the August rebound off the 0.61 low has visibly failed — the stock has rolled back under its SMA20 (0.94), EMA9 (0.97), WMA9 (0.97) and daily VWAP (0.9432), down ~4% intraday. Momentum confirms the fade: MACD (0.05/0.07/-0.01) is above zero but the histogram is negative and rolling over, RSI 53.5 is neutral, Williams %R -84.89 is near oversold, and ADX 46.96 shows strong trend energy now working against the bounce. The tape is also far too thin: 20-day average dollar volume ~$1.03M is below the $5M floor and the recent 3-session average ~$1.06M is below the $1.5M recent-liquidity floor. Verdict is Do Nothing on independent hard blocks: qualitativeScore 2 (< 3) from the upstream qualitative screen (deteriorating sentiment, Nasdaq listing deficiency, BofA downgrade) and the liquidity floors. Chart quality alone scores 2/5 — neutral/weak-bearish, bounce-only quality with the longer-term downtrend intact.